<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102338">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01681160</url>
  </required_header>
  <id_info>
    <org_study_id>86/116</org_study_id>
    <nct_id>NCT01681160</nct_id>
  </id_info>
  <brief_title>Study of Maggot Therapy in Diabetic Foot Ulcers</brief_title>
  <acronym>MDT</acronym>
  <official_title>Maggot Therapy in Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kerman Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kerman Medical University</source>
  <oversight_info>
    <authority>Iran: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was a Kind of clinical trial with equal randomization, that have been done from
      January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128
      diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is
      one of the more important aims for health professional specially for nurses.One of this new
      treatment is maggot therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 3days and change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 6 days</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>DIABETIC FOOT ULCERS</condition>
  <arm_group>
    <arm_group_label>MAGGOT THERAPY &amp; conventional therapy T</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maggot therapy,ADMINISTERED TWO TIMES AS A NEW METHODS OF DRESSING in experimental group.conventional therapy ,administered two times in control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>procedure:maggot therapy</intervention_name>
    <description>each times in maggot therapy continued for three days.wound assessment was done before and after any intervention</description>
    <arm_group_label>MAGGOT THERAPY &amp; conventional therapy T</arm_group_label>
    <other_name>larval therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional therapy</intervention_name>
    <description>patients receive ordinary treatment for diabetic foot</description>
    <arm_group_label>MAGGOT THERAPY &amp; conventional therapy T</arm_group_label>
    <other_name>mechanical debridement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a chronic illness more than 7 weeks.

          -  The age of the patients between 40- 90 years old.

          -  Not having capillary disease (Blockage of artery, Rinold).

          -  Not user of anticoagulants and corticosteroids drugs.

          -  Patients without history of allergy to drugs and foods.

          -  Having diabetic type 2

        Exclusion Criteria:

          -  patients who refer to critical clinical care unit

          -  patients who have amputation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 7, 2012</lastchanged_date>
  <firstreceived_date>September 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kerman Medical University</investigator_affiliation>
    <investigator_full_name>Forough Pouryazdanpanah Kermani</investigator_full_name>
    <investigator_title>university instructor</investigator_title>
  </responsible_party>
  <keyword>MAGGOT THERAPY</keyword>
  <keyword>DIABETIC FOOT</keyword>
  <keyword>NURSING CARE</keyword>
  <keyword>DRESSING</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
